Papers associated with gabarap

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 8 9 10 11 12 13 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

referenced by:

	Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit., Harris D, Clayton T, Cook J, Sahbaie P, Halliwell RF, Furtmüller R, Huck S, Sieghart W, DeLorey TM., J Med Chem. July 10, 2008; 51 (13): 3788-803.
	Individually monitoring ligand-induced changes in the structure of the GABAA receptor at benzodiazepine binding site and non-binding-site interfaces., Sharkey LM, Czajkowski C., Mol Pharmacol. July 1, 2008; 74 (1): 203-12.
	Effects on membrane capacitance of steroids with antagonist properties at GABAA receptors., Mennerick S, Lamberta M, Shu HJ, Hogins J, Wang C, Covey DF, Eisenman LN, Zorumski CF., Biophys J. July 1, 2008; 95 (1): 176-85.
	Pharmacological Properties of DOV 315,090, an ocinaplon metabolite., Berezhnoy D, Gravielle MC, Downing S, Kostakis E, Basile AS, Skolnick P, Gibbs TT, Farb DH., BMC Pharmacol. June 13, 2008; 8 11.
	Effect of dried bonito (katsuobushi) and some of its components on GABAA receptors., Mitou M, Shigemori Y, Aoshima H, Yokoyama S., Food Chem. June 1, 2008; 108 (3): 840-6.
	Histamine action on vertebrate GABAA receptors: direct channel gating and potentiation of GABA responses., Saras A, Gisselmann G, Vogt-Eisele AK, Erlkamp KS, Kletke O, Pusch H, Hatt H., J Biol Chem. April 18, 2008; 283 (16): 10470-5.
	HPLC-based activity profiling approach for the discovery of GABAA receptor ligands using an automated two microelectrode voltage clamp assay on Xenopus oocytes., Kim HJ, Baburin I, Khom S, Hering S, Hamburger M., Planta Med. April 1, 2008; 74 (5): 521-6.
	alpha1beta2delta, a silent GABAA receptor: recruitment by tracazolate and neurosteroids., Zheleznova N, Sedelnikova A, Weiss DS., Br J Pharmacol. March 1, 2008; 153 (5): 1062-71.
	The promiscuous role of the epsilon subunit in GABAA receptor biogenesis., Bollan KA, Baur R, Hales TG, Sigel E, Connolly CN., Mol Cell Neurosci. March 1, 2008; 37 (3): 610-21.
	Mechanisms of potentiation of the mammalian GABAA receptor by the marine cembranoid eupalmerin acetate., Li P, Reichert DE, Rodríguez AD, Manion BD, Evers AS, Eterović VA, Steinbach JH, Akk G., Br J Pharmacol. February 1, 2008; 153 (3): 598-608.
	Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?, Savić MM, Huang S, Furtmüller R, Clayton T, Huck S, Obradović DI, Ugresić ND, Sieghart W, Bokonjić DR, Cook JM., Neuropsychopharmacology. January 1, 2008; 33 (2): 332-9.
	Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid., Trauner G, Khom S, Baburin I, Benedek B, Hering S, Kopp B., Planta Med. January 1, 2008; 74 (1): 19-24.
	Identification of a domain in the delta subunit (S238-V264) of the alpha4beta3delta GABAA receptor that confers high agonist sensitivity., You H, Dunn SM., J Neurochem. November 1, 2007; 103 (3): 1092-101.
	Antagonism of neurosteroid modulation of native gamma-aminobutyric acid receptors by (3alpha,5alpha)-17-phenylandrost-16-en-3-ol., Kelley SP, Alan JK, O'Buckley TK, Mennerick S, Krishnan K, Covey DF, Leslie Morrow A., Eur J Pharmacol. October 31, 2007; 572 (2-3): 94-101.
	The antiepileptic drug levetiracetam stabilizes the human epileptic GABAA receptors upon repetitive activation., Palma E, Ragozzino D, Di Angelantonio S, Mascia A, Maiolino F, Manfredi M, Cantore G, Esposito V, Di Gennaro G, Quarato P, Miledi R, Eusebi F., Epilepsia. October 1, 2007; 48 (10): 1842-9.
	Neuroactive steroids and human recombinant rho1 GABAC receptors., Li W, Jin X, Covey DF, Steinbach JH., J Pharmacol Exp Ther. October 1, 2007; 323 (1): 236-47.
	Transducing agonist binding to channel gating involves different interactions in 5-HT3 and GABAC receptors., Price KL, Millen KS, Lummis SC., J Biol Chem. August 31, 2007; 282 (35): 25623-30.
	Electrophysiological properties and subunit composition of GABAA receptors in patients with gelastic seizures and hypothalamic hamartoma., Wu J, Chang Y, Li G, Xue F, DeChon J, Ellsworth K, Liu Q, Yang K, Bahadroani N, Zheng C, Zhang J, Rekate H, Rho JM, Kerrigan JF., J Neurophysiol. July 1, 2007; 98 (1): 5-15.
	C-terminal modification is required for GABARAP-mediated GABA(A) receptor trafficking., Chen ZW, Chang CS, Leil TA, Olsen RW., J Neurosci. June 20, 2007; 27 (25): 6655-63.
	Rat alpha6beta2delta GABAA receptors exhibit two distinct and separable agonist affinities., Hadley SH, Amin J., J Physiol. June 15, 2007; 581 (Pt 3): 1001-18.
	Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators., Ng HJ, Whittemore ER, Tran MB, Hogenkamp DJ, Broide RS, Johnstone TB, Zheng L, Stevens KE, Gee KW., Proc Natl Acad Sci U S A. May 8, 2007; 104 (19): 8059-64.
	Modulation of GABAA receptors in cerebellar granule neurons by ethanol: a review of genetic and electrophysiological studies., Botta P, Radcliffe RA, Carta M, Mameli M, Daly E, Floyd KL, Deitrich RA, Valenzuela CF., Alcohol. May 1, 2007; 41 (3): 187-99.
	4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure-activity relationships., Frølund B, Jensen LS, Storustovu SI, Stensbøl TB, Ebert B, Kehler J, Krogsgaard-Larsen P, Liljefors T., J Med Chem. April 19, 2007; 50 (8): 1988-92.
	Changes in the function of the inhibitory neurotransmitter system in the rat brain following subchronic inhalation exposure to 1-bromopropane., Ueno S, Yoshida Y, Fueta Y, Ishidao T, Liu J, Kunugita N, Yanagihara N, Hori H., Neurotoxicology. March 1, 2007; 28 (2): 415-20.
	Agonist-, antagonist-, and benzodiazepine-induced structural changes in the alpha1 Met113-Leu132 region of the GABAA receptor., Kloda JH, Czajkowski C., Mol Pharmacol. February 1, 2007; 71 (2): 483-93.
	The location of a closed channel gate in the GABAA receptor channel., Bali M, Akabas MH., J Gen Physiol. February 1, 2007; 129 (2): 145-59.
	Imaging GABAc receptors with ligand-conjugated quantum dots., Tomlinson ID, Gussin HA, Little DM, Warnement MR, Qian H, Pepperberg DR, Rosenthal SJ., J Biomed Biotechnol. January 1, 2007; 2007 76514.
	The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors., Popik P, Kostakis E, Krawczyk M, Nowak G, Szewczyk B, Krieter P, Chen Z, Russek SJ, Gibbs TT, Farb DH, Skolnick P, Lippa AS, Basile AS., J Pharmacol Exp Ther. December 1, 2006; 319 (3): 1244-52.
	Stoichiometry of a pore mutation that abolishes picrotoxin-mediated antagonism of the GABAA receptor., Sedelnikova A, Erkkila BE, Harris H, Zakharkin SO, Weiss DS., J Physiol. December 1, 2006; 577 (Pt 2): 569-77.
	The proconvulsant effects of the GABAA alpha5 subtype-selective compound RY-080 may not be alpha5-mediated., Atack JR, Bayley PJ, Fletcher SR, McKernan RM, Wafford KA, Dawson GR., Eur J Pharmacol. October 24, 2006; 548 (1-3): 77-82.
	Synthesis of trifluoromethylaryl diazirine and benzophenone derivatives of etomidate that are potent general anesthetics and effective photolabels for probing sites on ligand-gated ion channels., Husain SS, Nirthanan S, Ruesch D, Solt K, Cheng Q, Li GD, Arevalo E, Olsen RW, Raines DE, Forman SA, Cohen JB, Miller KW., J Med Chem. August 10, 2006; 49 (16): 4818-25.
	Mechanism of action of benzodiazepines on GABAA receptors., Campo-Soria C, Chang Y, Weiss DS., Br J Pharmacol. August 1, 2006; 148 (7): 984-90.
	Neurosteroid analogues. 11. Alternative ring system scaffolds: gamma-aminobutyric acid receptor modulation and anesthetic actions of benz[f]indenes., Scaglione JB, Manion BD, Benz A, Taylor A, DeKoster GT, Rath NP, Evers AS, Zorumski CF, Mennerick S, Covey DF., J Med Chem. July 27, 2006; 49 (15): 4595-605.
	Low-dose alcohol actions on alpha4beta3delta GABAA receptors are reversed by the behavioral alcohol antagonist Ro15-4513., Wallner M, Hanchar HJ, Olsen RW., Proc Natl Acad Sci U S A. May 30, 2006; 103 (22): 8540-5.
	Interleukin-1beta enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy., Serantes R, Arnalich F, Figueroa M, Salinas M, Andrés-Mateos E, Codoceo R, Renart J, Matute C, Cavada C, Cuadrado A, Montiel C., J Biol Chem. May 26, 2006; 281 (21): 14632-43.
	Depolarizing GABAergic conductances regulate the balance of excitation to inhibition in the developing retinotectal circuit in vivo., Akerman CJ, Cline HT., J Neurosci. May 10, 2006; 26 (19): 5117-30.
	State-dependent cross-linking of the M2 and M3 segments: functional basis for the alignment of GABAA and acetylcholine receptor M3 segments., Jansen M, Akabas MH., J Neurosci. April 26, 2006; 26 (17): 4492-9.
	Contributions of the GABAA receptor alpha6 subunit to phasic and tonic inhibition revealed by a naturally occurring polymorphism in the alpha6 gene., Santhakumar V, Hanchar HJ, Wallner M, Olsen RW, Otis TS., J Neurosci. March 22, 2006; 26 (12): 3357-64.
	An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability., Barela AJ, Waddy SP, Lickfett JG, Hunter J, Anido A, Helmers SL, Goldin AL, Escayg A., J Neurosci. March 8, 2006; 26 (10): 2714-23.
	An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition., Dawson GR, Maubach KA, Collinson N, Cobain M, Everitt BJ, MacLeod AM, Choudhury HI, McDonald LM, Pillai G, Rycroft W, Smith AJ, Sternfeld F, Tattersall FD, Wafford KA, Reynolds DS, Seabrook GR, Atack JR., J Pharmacol Exp Ther. March 1, 2006; 316 (3): 1335-45.
	Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2., Stórustovu SI, Ebert B., J Pharmacol Exp Ther. March 1, 2006; 316 (3): 1351-9.
	Charged residues in the alpha1 and beta2 pre-M1 regions involved in GABAA receptor activation., Mercado J, Czajkowski C., J Neurosci. February 15, 2006; 26 (7): 2031-40.
	Pharmacological properties of GABAA receptors containing gamma1 subunits., Khom S, Baburin I, Timin EN, Hohaus A, Sieghart W, Hering S., Mol Pharmacol. February 1, 2006; 69 (2): 640-9.
	Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytes., Ranna M, Sinkkonen ST, Möykkynen T, Uusi-Oukari M, Korpi ER., BMC Pharmacol. January 13, 2006; 6 1.
	Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types., Moroni M, Bermudez I., J Mol Neurosci. January 1, 2006; 30 (1-2): 95-6.
	Protons inhibit Cl- conductance by direct or allosteric interaction with the GABA-binding site in the rat recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptor., Wang MD, Rahman M, Zhu D., Eur J Pharmacol. December 28, 2005; 528 (1-3): 1-6.
	Novel plant substances acting as beta subunit isoform-selective positive allosteric modulators of GABAA receptors., Baur R, Simmen U, Senn M, Séquin U, Sigel E., Mol Pharmacol. September 1, 2005; 68 (3): 787-92.
	Selective GABAA alpha5 benzodiazepine inverse agonist antagonizes the neurobehavioral actions of alcohol., Cook JB, Foster KL, Eiler WJ, McKay PF, Woods J, Harvey SC, Garcia M, Grey C, McCane S, Mason D, Cummings R, Li X, Cook JM, June HL., Alcohol Clin Exp Res. August 1, 2005; 29 (8): 1390-401.
	Single-amino-acid difference in the sequence of alpha6 subunit dramatically increases the ethanol sensitivity of recombinant GABAA receptors., Valenzuela CF, Mameli M, Carta M., Alcohol Clin Exp Res. July 1, 2005; 29 (7): 1356-7; author reply 1358.
	GABAA receptor-associated protein regulates GABAA receptor cell-surface number in Xenopus laevis oocytes., Chen ZW, Chang CS, Leil TA, Olcese R, Olsen RW., Mol Pharmacol. July 1, 2005; 68 (1): 152-9.

???pagination.result.page??? ???pagination.result.prev??? 1 2 3 4 5 6 7 8 9 10 11 12 13 ???pagination.result.next???